156 related articles for article (PubMed ID: 29726030)
1. Distinguishing between irritated seborrheic keratosis and squamous cell carcinoma in situ using BCL-2 and IMP3 immunohistochemistry.
Richey JD; Deng AC; Dresser K; O'Donnell P; Cornejo KM
J Cutan Pathol; 2018 Aug; 45(8):603-609. PubMed ID: 29726030
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis.
Gaballah MA; Ahmed RA
Pathol Res Pract; 2015 Dec; 211(12):931-8. PubMed ID: 26573127
[TBL] [Abstract][Full Text] [Related]
3. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2-positive epidermal dendritic cells in inverted follicular keratoses but not squamous cell carcinomas or seborrheic keratoses.
Ko CJ; Kim J; Phan J; Binder SW
J Cutan Pathol; 2006 Jul; 33(7):498-501. PubMed ID: 16872473
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor 2 mRNA-binding protein-3 as a marker for distinguishing between cutaneous squamous cell carcinoma and keratoacanthoma.
Kanzaki A; Kudo M; Ansai S; Peng WX; Ishino K; Yamamoto T; Wada R; Fujii T; Teduka K; Kawahara K; Kawamoto Y; Kitamura T; Kawana S; Saeki H; Naito Z
Int J Oncol; 2016 Mar; 48(3):1007-15. PubMed ID: 26782292
[TBL] [Abstract][Full Text] [Related]
6. Discrimination of squamous cell carcinoma in situ from seborrheic keratosis by color analysis techniques requires information from scale, scale-crust and surrounding areas in dermoscopy images.
Shakya NM; LeAnder RW; Hinton KA; Stricklin SM; Rader RK; Hagerty J; Stoecker WV
Comput Biol Med; 2012 Dec; 42(12):1165-9. PubMed ID: 23117020
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous malignancies simulating seborrheic keratoses: An underappreciated phenomenon?
Chen TY; Morrison AO; Cockerell CJ
J Cutan Pathol; 2017 Sep; 44(9):747-748. PubMed ID: 28589622
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
[TBL] [Abstract][Full Text] [Related]
9. Dermoscopy of clonal seborrheic keratosis.
Ramyead S; Diaz-Cano SJ; Pozo-Garcia L
J Am Acad Dermatol; 2015 Aug; 73(2):e47-9. PubMed ID: 26183995
[No Abstract] [Full Text] [Related]
10. IMP-3 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.
Soddu S; Di Felice E; Cabras S; Castellanos ME; Atzori L; Faa G; Pilloni L
Eur J Histochem; 2013 Feb; 57(1):e6. PubMed ID: 23549465
[TBL] [Abstract][Full Text] [Related]
11. Clinical misdiagnosis of squamous cell carcinoma in situ as seborrheic keratosis. A prospective study.
Sloan JB; Jaworsky C
J Dermatol Surg Oncol; 1993 May; 19(5):413-6. PubMed ID: 8496484
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of dermoscopic criteria for the differential diagnosis between irritated seborrheic keratosis and squamous cell carcinoma.
Papageorgiou C; Spyridis I; Manoli SM; Busila I; Nasturica IE; Lallas K; Panagopoulou A; Papadimitriou I; Sideris N; Gentsidi T; Gonzalez-Cuevas R; Ilieva A; Ioannides D; Apalla Z; Lallas A
J Am Acad Dermatol; 2021 Nov; 85(5):1143-1150. PubMed ID: 32068050
[TBL] [Abstract][Full Text] [Related]
13. [Expression of Oct-4 transcription factor in squamous cell skin carcinoma and seborrheic keratosis].
Li YY; Dai YJ; Deng B; Liang XA; Xie ZJ; Chen HF
Nan Fang Yi Ke Da Xue Xue Bao; 2011 May; 31(5):917-8. PubMed ID: 21602158
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical staining for p16 is a useful adjunctive test in the diagnosis of Bowen's disease.
Harvey NT; Leecy T; Wood BA
Pathology; 2013 Jun; 45(4):402-7. PubMed ID: 23635817
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratin 10-negative nested pattern enables sure distinction of clonal seborrheic keratosis from pagetoid Bowen's disease.
Böer-Auer A; Jones M; Lyasnichaya OV
J Cutan Pathol; 2012 Feb; 39(2):225-33. PubMed ID: 22236073
[TBL] [Abstract][Full Text] [Related]
16. Oncofetal protein IMP3: a new diagnostic biomarker for laryngeal carcinoma.
Chen K; Cornejo KM; Ye W; Wu Q; Liang J; Jiang Z
Hum Pathol; 2013 Oct; 44(10):2126-31. PubMed ID: 23806529
[TBL] [Abstract][Full Text] [Related]
17. Microinvasive squamous cell carcinoma arising within seborrheic keratosis.
Terada T; Kamo M; Baba Y; Sugiura M
Cutis; 2012 Oct; 90(4):176-8. PubMed ID: 23259202
[TBL] [Abstract][Full Text] [Related]
18. Squamous eddies in irritated seborrheic keratosis.
Choi HJ; Yun SK; Kim HU; Ihm CW
Am J Dermatopathol; 2007 Feb; 29(1):28-31. PubMed ID: 17284959
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor II-messenger RNA-binding protein-3 and lung cancer.
Findeis-Hosey JJ; Xu H
Biotech Histochem; 2012 Jan; 87(1):24-9. PubMed ID: 21838610
[TBL] [Abstract][Full Text] [Related]
20. The expression of p63 in actinic keratoses, seborrheic keratosis, and cutaneous squamous cell carcinomas.
Wrone DA; Yoo S; Chipps LK; Moy RL
Dermatol Surg; 2004 Oct; 30(10):1299-302. PubMed ID: 15458526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
